Items where authors include "Richardson, J.D."

Article

Sammut, M.A. orcid.org/0000-0003-3756-4726, Conway, D., Iqbal, J. et al. (7 more authors) (2024) Duration of triple antithrombotic therapy and clinical outcomes after percutaneous coronary intervention in atrial fibrillation. Expert Review of Cardiovascular Therapy, 22 (7). pp. 339-345. ISSN 1477-9072

Gosling, D.R.C., Adam, Z., Barmby, D.S. et al. (8 more authors) (2021) The impact of virtual fractional flow reserve and virtual coronary intervention upon treatment decisions in the cardiac catheter laboratory. Canadian Journal of Cardiology, 37 (10). pp. 1530-1538. ISSN 0828-282X

Sumaya, W., Parker, W.A.E. orcid.org/0000-0002-7822-8852, Judge, H.M. et al. (8 more authors) (2021) Prolonged enoxaparin therapy compared with standard-of-care antithrombotic therapy in opiate-treated patients undergoing primary percutaneous coronary intervention. Platelets, 32 (4). pp. 555-559. ISSN 0953-7104

Zwart, B., Yazdani, M., Ow, K.W. et al. (4 more authors) (2019) Use of glycoprotein IIb/IIIa antagonists to prevent stent thrombosis in morphine-treated patients with ST-elevation myocardial infarction. Platelets, 31 (2). pp. 174-178. ISSN 0953-7104

Orme, R.C., Parker, W.A.E., Thomas, M.R. et al. (13 more authors) (2018) Study of two dose regimens of ticagrelor compared with clopidogrel in patients undergoing percutaneous coronary intervention for stable coronary artery disease. Circulation, 138 (13). pp. 1290-1300. ISSN 0009-7322

Sumaya, W., Parker, W.A.E. orcid.org/0000-0002-7822-8852, Fretwell, R. et al. (12 more authors) (2018) Pharmacodynamic Effects of a 6-Hour Regimen of Enoxaparin in Patients Undergoing Primary Percutaneous Coronary Intervention (PENNY PCI Study). Thrombosis and Haemostasis , 118 (7). pp. 1250-1256. ISSN 0340-6245